2006•Modern Digestion & InterventionRequires access

Comparison of serum pepsinogen between gastric cancer and duodenal ulcer patients

Li-ping He

Open publisher page 0 citations

Abstract

Objective To compare serum pepsinogen I, II levels between patients with gastric cancer (GC) and patients with duodenal ulcer (DU), and study their relationship with Helicobacter pylori (H.pylori) infection. Method Serum pepsinogen (PG)I, II were tested by TRFIA, and serum H.pylori-IgG was tested by ELISA in both 108 GC and 96 DU patients. Result There was a statistical difference of PGI level between GC and DU, but no difference of serum PGI, PGII level and PGI/PGII was found between H.pylori positive and negative patients with GC and DU. Conclusion PGI level is remarkably lower in GC patients than in DU patients, and H.pylori infection does not influence serum PGI?PGII levels and PGI/PGII in both GC and DU patients.

About this research paper

What this paper is about

Objective To compare serum pepsinogen I, II levels between patients with gastric cancer (GC) and patients with duodenal ulcer (DU), and study their relationship with Helicobacter pylori (H.pylori) infection. Method Serum pepsinogen (PG)I, II were tested by TRFIA, and serum H.pylori-IgG was tested by ELISA in both 108 GC and 96 DU patients. Result There was a statistical difference of PGI level between GC and DU, but no difference of serum PGI, PGII level and PGI/PGII was found between H.pylori positive and negative patients with GC and DU. Conclusion PGI level is remarkably lower in GC patients than in DU patients, and H.pylori infection does not influence serum PGI?PGII levels and PGI/PGII in both GC and DU patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare serum pepsinogen I, II levels between patients with gastric cancer (GC) and patients with duodenal ulcer (DU), and study their relationship with Helicobacter pylori (H.pylori) infection. Method Serum pepsinogen (PG)I, II were tested by TRFIA, and serum H.pylori-IgG was tested by ELISA in both 108 GC and 96 DU patients. Result There was a statistical difference of PGI level between GC and DU, but no difference of serum PGI, PGII level and PGI/PGII was found between H.pylori positive and negative patients with GC and DU. Conclusion PGI level is remarkably lower in GC patients than in DU patients, and H.pylori infection does not influence serum PGI?PGII levels and PGI/PGII in both GC and DU patients.

Key concepts: Gastroenterology, Internal medicine, Helicobacter pylori, Medicine, Pepsin, Cancer, Significant difference, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of serum pepsinogen between gastric cancer and duodenal ulcer patients — Research Paper | ScholarLens